Harrow

1 follower


Harrow (Nasdaq: HROW) is a leading U.S. eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic prescription therapies that are accessible and affordable. Harrow owns U.S. commercial rights to ten FDA-approved ophthalmic pharmaceutical pro... Read more

Industries

Headquarters

Employees

Links

Org chart

Mark L. Baum
CEO & Chairman

Mark L. Baum

Collapse
John P. Saharek
Chief Commercial Officer
Andrew R. Boll
Chief Financial Officer
Dennis E. Saadeh
Chief Scientific Officer
Kim Barratt
Chief Talent Officer
Mark Mannebach
Head of Regulatory Affairs & Pharmacovigilance
Garrett S.
Director Of Information Technology